Scientists are still investigating potential causes and treatments for autoimmune conditions. Here’s what to know. View on ...
A Pierce County woman alleges Rainier Recovery's negligent care contributed to her son's death, exposing a pattern of ...
When your body’s immune cells attack you instead of protecting you, today’s treatments tamp down the friendly fire but they ...
Two Phase 3 trials testing the investigational oral therapy fenebrutinib in people with multiple sclerosis (MS) have hit ...
What are called autoimmune diseases can affect just about every part of the body — and tens of millions of people. While most ...
Early intervention and effective therapies are transforming multiple sclerosis management, enhancing patient outcomes, and delaying disability progression.
This week, Amy Wechsler, a dermatologist in Manhattan, is introducing a side hustle of sorts: a street-level clinic called Spotless that aspires to be the Drybar of acne care, with a touch of a medspa ...
Fenebrutinib shows promise as the first BTK inhibitor for both RMS and PPMS, reducing relapses and slowing disability progression. The FENhance 2 study demonstrated fenebrutinib's efficacy over ...
A multinational research study assessed microplastic concentrations in the drinking water supply system of Amsterdam from source to tap using pyrolysis gas chromatography-mass spectrometry (Py-GC-MS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback